Increase Size Default Size Decrease Size
Select Theme Blue Theme Green Theme Brown Theme Cream Theme Standard View High Contrast View
Ministry of Health & Family Welfare - Government of India
Stop
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
News & Highlights
Nikshay Digital India[power to empower] STCI Directory of STOs National Health Mission

Performance Reports

Back

1. Definitions

    

  • Annualized Case Detection Rate for New Smear Positive Cases
    Is the number of new smear-positive tuberculosis cases registered for treatment per 100,000 population. In India, the estimated incidence of cases is 75 New smear-positive cases per 100,000 population per year. The global and the national target is to detect at least 70% of the total estimated cases - i.e. 53 cases per 100,000 per year.
     
  • Proportion of New Sputum positive out of Total New Pulmonary Cases
    In a well performing area, 50% of all new pulmonary cases would be sputum smear-positive (infectious, confirmed in the laboratory) case, i.e. there will be no more than approximately one smear-negative case for every smear-positive case. This proportion however should not be less than 45%.
     
  • Smear Conversion Rate
    Percentage of new smear positive (infectious) patients who are documented to have become non-infectious (smear-negative) within 3 months of starting treatment. In a well performing area, a conversion rate of at least 85-90% will be achieved. This indicator is reported one quarter (4-6 months) after patients are registered for treatment, and applies to every patient started on treatment, without exceptions.
     
  • Treatment Success Rate
    Percentage of new smear positive patients who are documented to be cured, or to be successfully completed treatment. In a well performing area, 80-85% of patients will be successfully treated. The global and national target is to achieve and maintain 85% treatment success. This indicator is reported 13-15 months after patient are registered for treatment, and applies to every patient started on treatment, without exceptions.